Coblation Versus Bipolar Diathermy in Management of Refractory Idiopathic Recurrent Anterior Epistaxis in Children.
Comparison Between Coblation Versus Bipolar Diathermy in Management of Refractory Idiopathic Recurrent Anterior Epistaxis in Children.
1 other identifier
interventional
64
0 countries
N/A
Brief Summary
The aim of this study is to compare the outcomes of coblation technique versus bipolar technique in management of RAE in children regarding the following:
- 1.Efficacy of each method to stop bleeding.
- 2.Technical feasibility.
- 3.Mucosal healing and crust formation.
- 4.Post operative complications like: synechia formation and septal perforation.
- 5.Nostril stenosis/ atresia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 19, 2024
CompletedFirst Posted
Study publicly available on registry
October 22, 2024
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedFebruary 19, 2025
February 1, 2025
9 months
October 19, 2024
February 15, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants with successful hemostasis on the day of the procedure.
No epistaxis within the first 24 hours of the procedure.
The first 24 hours postoperative
Secondary Outcomes (1)
Postoperative complications
6 months
Study Arms (2)
Group A: patients in this group will be managed with bipolar diathermy "Standard technique".
ACTIVE COMPARATORThe bipolar technique for group A: A bipolar with straight blade will be used with a footplate-operated switch to control the coagulation time, and the length, width and depth of penetration of the thermal power. The lesion will be coagulated in a distal-to-proximal direction to achieve a uniform gray-white coagulation zone in the lesion and surrounding tissue. Multiple ablations at the same area should be avoided to avoid septal perforation. After finishing coagulation small gauze impregnated with antibiotic ointment will be applied for 2 hours postoperatively.
Group B: patients in this group will be managed with coblation technique.
EXPERIMENTALThe coblation technique for group B: An coblator with tonsillar blade will be used with a footplate-operated switch to control the coagulation time, and the length, width and depth of penetration of the thermal power. The lesion will be coagulated in a distal-to-proximal direction to achieve a uniform gray-white coagulation zone in the lesion and surrounding tissue. Multiple ablations at the same area should be avoided to avoid septal perforation. After finishing coagulation small gauze impregnated with antibiotic ointment will be applied for 2 hours postoperatively.
Interventions
The bipolar technique for group A: A bipolar with straight blade will be used with a footplate-operated switch to control the coagulation time, and the length, width and depth of penetration of the thermal power. The lesion will be coagulated in a distal-to-proximal direction to achieve a uniform gray-white coagulation zone in the lesion and surrounding tissue. Multiple ablations at the same area should be avoided to avoid septal perforation. After finishing coagulation small gauze impregnated with antibiotic ointment will be applied for 2 hours postoperatively.
The coblation technique for group B: An coblator with tonsillar blade will be used with a footplate-operated switch to control the coagulation time, and the length, width and depth of penetration of the thermal power. The lesion will be coagulated in a distal-to-proximal direction to achieve a uniform gray-white coagulation zone in the lesion and surrounding tissue. Multiple ablations at the same area should be avoided to avoid septal perforation. After finishing coagulation small gauze impregnated with antibiotic ointment will be applied for 2 hours postoperatively.
Eligibility Criteria
You may qualify if:
- A history of repeated unilateral epistaxis with at least four episodes, at least one episode per week during the preceding 4 weeks.
- Age \> 5 years of age and \< 18 years of age.
- Failure of topical treatment with an antiseptic ointment, with or without silver nitrate cautery.
- A Katsanis epistaxis scoring system (ESS) score of 7-10.
- Bleeding originating from Kiesselbach's plexus, located in the anteroinferior portion of the nasal septum.
You may not qualify if:
- Patients \< 5 years of age and \>= 18 years of age.
- Patients with bilateral epistaxis.
- Patients with bleeding tendencies like: Hemophilia, Leukemia, Idiopathic thrombocytopenic purpura, Von Willebrand disease and Thrombasthenia.
- Patients with previous nasal surgeries.
- Patients with hereditary hemorrhagic telangiectasia.
- Patients with vascular lesions like: angiofibroma, pyogenic granuloma and bleeding polypus.
- Patients who are unfit for surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Lou ZC. Hemostasis of idiopathic recurrent epistaxis in children with microwave ablation: a prospective pilot case series. J Otolaryngol Head Neck Surg. 2019 Dec 18;48(1):72. doi: 10.1186/s40463-019-0393-0.
PMID: 31852515BACKGROUND
Study Officials
- STUDY CHAIR
Aly R Selim, Professor
Professor
- STUDY DIRECTOR
Shimaa I Abdallah, Ass.Prof
Assistant Professor
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
October 19, 2024
First Posted
October 22, 2024
Study Start
March 1, 2025
Primary Completion
December 1, 2025
Study Completion
January 1, 2026
Last Updated
February 19, 2025
Record last verified: 2025-02